These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25062506)

  • 41. Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior.
    Váradi A; Marrone GF; Eans SO; Ganno ML; Subrath JJ; Le Rouzic V; Hunkele A; Pasternak GW; McLaughlin JP; Majumdar S
    ACS Chem Neurosci; 2015 Nov; 6(11):1813-24. PubMed ID: 26325040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arylacetamides as peripherally restricted kappa opioid receptor agonists.
    Kumar V; Marella MA; Cortes-Burgos L; Chang AC; Cassel JA; Daubert JD; DeHaven RN; DeHaven-Hudkins DL; Gottshall SL; Mansson E; Maycock AL
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2567-70. PubMed ID: 11086731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, chemical synthesis, and biological evaluation of thiosaccharide analogues of morphine- and codeine-6-glucuronide.
    MacDougall JM; Zhang XD; Polgar WE; Khroyan TV; Toll L; Cashman JR
    J Med Chem; 2004 Nov; 47(23):5809-15. PubMed ID: 15509180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and synthesis of novel δ opioid receptor agonists with an azatricyclodecane skeleton for improving blood-brain barrier penetration.
    Watanabe Y; Hayashida K; Saito D; Takahashi T; Sakai J; Nakata E; Kanda T; Iwai T; Hirayama S; Fujii H; Yamakawa T; Nagase H
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3495-3498. PubMed ID: 28602640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities.
    Li W; Long JD; Qian YY; Long Y; Xu XJ; Wang YJ; Shen Q; Wang ZN; Yang XC; Xiao L; Sun HP; Xu YL; Chen YY; Xie Q; Wang YH; Shao LM; Liu JG; Qiu ZB; Fu W
    ACS Chem Neurosci; 2017 Apr; 8(4):766-776. PubMed ID: 28033462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery, structure-activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists.
    Cheng MF; Ou LC; Chen SC; Chang WT; Law PY; Loh HH; Chao YS; Shih C; Yeh SH; Ueng SH
    Bioorg Med Chem; 2014 Sep; 22(17):4694-703. PubMed ID: 25087049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and binding affinity of cis-(-)- and cis-(+)-N-ethyleneamino-N-nordeoxymetazocine and cis-(-)-N-normetazocine analogues at sigma1, sigma2 and kappa opioid receptors.
    Ronsisvalle G; Prezzavento O; Marrazzo A; Vittorio F; Bousquet E; Di Toro R; Spampinato S
    Eur J Pharm Sci; 2001 Jan; 12(3):277-84. PubMed ID: 11113647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats.
    Negus SS; O'Connell R; Morrissey E; Cheng K; Rice KC
    J Pharmacol Exp Ther; 2012 Mar; 340(3):501-9. PubMed ID: 22128346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models.
    Jain MR; Patel RB; Prajapati KD; Vyas P; Bandyopadhyay D; Prajapati V; Bahekar R; Patel PN; Kawade HM; Kokare DM; Pawar V; Desai R
    Eur J Pharmacol; 2022 Jun; 924():174961. PubMed ID: 35443192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and structure--activity relationship of novel aminotetralin derivatives with high micro selective opioid affinity.
    Roy C; Li T; Krasik P; Gilbert MJ; Pelletier C; Gagnon D; Robert E; Ducharme J; Storer R; Lavallée JF
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3141-3. PubMed ID: 12372519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery, stereospecific characterization and peripheral modification of 1-(pyrrolidin-1-ylmethyl)-2-[(6-chloro-3-oxo-indan)-formyl]-1,2,3,4-tetrahydroisoquinolines as novel selective κ opioid receptor agonists.
    Gan ZJ; Wang YH; Xu YG; Guo T; Wang J; Song Q; Xu XJ; Hu SY; Wang YJ; Wang DC; Sun DZ; Zhang D; Xi T; Li HD; Zhang HB; Hang TJ; Lu HG; Liu JG
    Org Biomol Chem; 2015 May; 13(20):5656-73. PubMed ID: 25895552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A one-pot multicomponent approach to a new series of morphine derivatives and their biological evaluation.
    Shao J; Houghten RA; Dooley CT; Cazares M; McLaughlin JP; Eans SO; Ganno ML; Hoot MR; Giulianotti MA; Yu Y
    Org Biomol Chem; 2017 Sep; 15(37):7796-7801. PubMed ID: 28875208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
    Albert-Vartanian A; Boyd MR; Hall AL; Morgado SJ; Nguyen E; Nguyen VP; Patel SP; Russo LJ; Shao AJ; Raffa RB
    J Clin Pharm Ther; 2016 Aug; 41(4):371-82. PubMed ID: 27245498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines.
    Yamamoto T; Nair P; Jacobsen NE; Kulkarni V; Davis P; Ma SW; Navratilova E; Yamamura HI; Vanderah TW; Porreca F; Lai J; Hruby VJ
    J Med Chem; 2010 Aug; 53(15):5491-501. PubMed ID: 20617791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: part 3, novel propellane derivatives with pentacyclic skeletons.
    Fujii H; Nakajima R; Akiyama J; Yamamoto N; Hirayama S; Nemoto T; Gouda H; Hirono S; Nagase H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7697-701. PubMed ID: 23116891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of Carfentanil Amide Opioids Using the Ugi Multicomponent Reaction.
    Váradi A; Palmer TC; Haselton N; Afonin D; Subrath JJ; Le Rouzic V; Hunkele A; Pasternak GW; Marrone GF; Borics A; Majumdar S
    ACS Chem Neurosci; 2015 Sep; 6(9):1570-7. PubMed ID: 26148793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF
    Piekielna-Ciesielska J; Mollica A; Pieretti S; Fichna J; Szymaszkiewicz A; Zielińska M; Kordek R; Janecka A
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):560-566. PubMed ID: 29513114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives.
    Piras S; Murineddu G; Loriga G; Carta A; Battistello E; Merighi S; Gessi S; Corona P; Asproni B; Ibba R; Temml V; Schuster D; Pinna GA
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3-Pyrroline containing arylacetamides: a novel series of remarkably selective kappa-agonists.
    Mou QY; Chen J; Zhu YC; Zhou DH; Chi ZQ; Long YQ
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2287-90. PubMed ID: 12161117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ
    García M; Virgili M; Alonso M; Alegret C; Farran J; Fernández B; Bordas M; Pascual R; Burgueño J; Vidal-Torres A; Fernández de Henestrosa AR; Ayet E; Merlos M; Vela JM; Plata-Salamán CR; Almansa C
    J Med Chem; 2020 Dec; 63(24):15508-15526. PubMed ID: 33064947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.